FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1442691982> ?p ?o ?g. }

• W1442691982 abstract "INTRODUCTION: In patients submitted to neoadjuvant chemotherapy (NC), the breast conservative surgery (BCS) rates vary from 37 to 82%, but it occurs in 1.7% to 28% of patients with locally advanced breast cancer (LABC), which constitutes a sub-group of patients. One way to assess the safety of the BCS after NC is by analyzing recurrence rate. The tumor margins, the form of tumor fragmentation after NC and tumor characteristics are the main factors related to Ipsilateral Breast Tumor Recurrence (IBTR).MATERIAL AND METHODS: A retrospective study approved by the Ethics committee (112/2007) evaluating patients with LABC who were seen in the period from 01/2006 10/2009, and submitted to NC based on 4 cycles of doxorubicin + cyclophosphamide followed by 4 cycles of Docetaxel. BCS was considered when breast or skin was preserved, so this group represents patients submitted to quadrantectomy or skin sparing mastectomy. We evaluated factors related to the IBTR in univariate analysis.RESULTS: A total of 321 patients undergoing chemotherapy, 78 underwent BCS. The age ranged between 21-73 years (median 45.1 years). The clinical tumor size ranged from 1.4 to 9.0 cm (median 5.5 cm). The main histological type was invasive ductal carcinoma (92.3%). There are 6.4% in clinical stage II, 60.3% IIIa, 28.2% IIIb and 5.1% IIIb. Concerning immunohistochemistry expression, 57.7% had estrogen receptor positive, 52.6% progesterone receptor positive and 82.1% HER-2 negative. of the total, 19.2% (15) underwent skin sparing mastectomy and 80.8% quadrantectomy. 2 affected margins (2.6%) were observed. All patients underwent adjuvant radiotherapy and 47.7% to hormonal therapy. Follow-up ranged from 4.5 to 38.4 months (median 19.3 months). At the end of the study 9.0% were alive with disease, 3.8% died from the disease, 2% had lost the follow up, and the others were alive and without disease. The IBTR rate was 9.0%. Local recurrences were more frequent in patients with estrogen receptor negative (p = 0.02), progesterone receptor negative (p = 0.02), EC IIIA (p = 0.50), pT3 (p = 0.73), submitted to quadrantectomy (p = 0.62). The margin (p=0.78) did not influence the recurrence rate.Discussion:Tumor margins and tumor characteristics are the main factors related to IBTR. IBTR occurs 12.7% in patients with clear margins, 15% when the margin is smaller than 15mm and 20.3% positive margins. Besides large tumors and limited follow up, our study was unable to find differences related to margin, because of its low presentation in those cases. IBTR occurs in 0,8% of tumors luminal A and 7,1% of tumors basal-like, but there is no study evaluating that fact in LACB and NC. We observed higher IBTR in the absence of expression of hormonal receptor fact that makes our findings of particular interest.CONCLUSION: The rate of IBTR was acceptable, which justifies this therapy in selected patients. More studies are necessary to evaluate the role of biological characteristics of the tumor and its role in the margin on the LABC." @default.
• W1442691982 created "2016-06-24" @default.
• W1442691982 creator A5018058360 @default.
• W1442691982 creator A5020525223 @default.
• W1442691982 creator A5021213643 @default.
• W1442691982 creator A5037445654 @default.
• W1442691982 creator A5038084423 @default.
• W1442691982 creator A5038478455 @default.
• W1442691982 creator A5049610479 @default.
• W1442691982 creator A5057654141 @default.
• W1442691982 date "2012-10-10" @default.
• W1442691982 modified "2023-09-27" @default.
• W1442691982 title "Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer. Factors Related to Ipsilateral Breast Recurrence in Patients Submitted to Conservative Surgery" @default.
• W1442691982 doi "https://doi.org/10.7170/jsis.v1i3.367" @default.
• W1442691982 hasPublicationYear "2012" @default.
• W1442691982 type Work @default.
• W1442691982 sameAs 1442691982 @default.
• W1442691982 citedByCount "0" @default.
• W1442691982 crossrefType "journal-article" @default.
• W1442691982 hasAuthorship W1442691982A5018058360 @default.
• W1442691982 hasAuthorship W1442691982A5020525223 @default.
• W1442691982 hasAuthorship W1442691982A5021213643 @default.
• W1442691982 hasAuthorship W1442691982A5037445654 @default.
• W1442691982 hasAuthorship W1442691982A5038084423 @default.
• W1442691982 hasAuthorship W1442691982A5038478455 @default.
• W1442691982 hasAuthorship W1442691982A5049610479 @default.
• W1442691982 hasAuthorship W1442691982A5057654141 @default.
• W1442691982 hasConcept C121608353 @default.
• W1442691982 hasConcept C126322002 @default.
• W1442691982 hasConcept C141071460 @default.
• W1442691982 hasConcept C143998085 @default.
• W1442691982 hasConcept C144301174 @default.
• W1442691982 hasConcept C146357865 @default.
• W1442691982 hasConcept C151730666 @default.
• W1442691982 hasConcept C2776694085 @default.
• W1442691982 hasConcept C2776755627 @default.
• W1442691982 hasConcept C2777757722 @default.
• W1442691982 hasConcept C2778115633 @default.
• W1442691982 hasConcept C2779572924 @default.
• W1442691982 hasConcept C2781190966 @default.
• W1442691982 hasConcept C2781467025 @default.
• W1442691982 hasConcept C38180746 @default.
• W1442691982 hasConcept C530470458 @default.
• W1442691982 hasConcept C71924100 @default.
• W1442691982 hasConcept C84606932 @default.
• W1442691982 hasConcept C86803240 @default.
• W1442691982 hasConceptScore W1442691982C121608353 @default.
• W1442691982 hasConceptScore W1442691982C126322002 @default.
• W1442691982 hasConceptScore W1442691982C141071460 @default.
• W1442691982 hasConceptScore W1442691982C143998085 @default.
• W1442691982 hasConceptScore W1442691982C144301174 @default.
• W1442691982 hasConceptScore W1442691982C146357865 @default.
• W1442691982 hasConceptScore W1442691982C151730666 @default.
• W1442691982 hasConceptScore W1442691982C2776694085 @default.
• W1442691982 hasConceptScore W1442691982C2776755627 @default.
• W1442691982 hasConceptScore W1442691982C2777757722 @default.
• W1442691982 hasConceptScore W1442691982C2778115633 @default.
• W1442691982 hasConceptScore W1442691982C2779572924 @default.
• W1442691982 hasConceptScore W1442691982C2781190966 @default.
• W1442691982 hasConceptScore W1442691982C2781467025 @default.
• W1442691982 hasConceptScore W1442691982C38180746 @default.
• W1442691982 hasConceptScore W1442691982C530470458 @default.
• W1442691982 hasConceptScore W1442691982C71924100 @default.
• W1442691982 hasConceptScore W1442691982C84606932 @default.
• W1442691982 hasConceptScore W1442691982C86803240 @default.
• W1442691982 hasIssue "3" @default.
• W1442691982 hasLocation W14426919821 @default.
• W1442691982 hasOpenAccess W1442691982 @default.
• W1442691982 hasPrimaryLocation W14426919821 @default.
• W1442691982 hasRelatedWork W1818055041 @default.
• W1442691982 hasRelatedWork W1963653929 @default.
• W1442691982 hasRelatedWork W1965160522 @default.
• W1442691982 hasRelatedWork W1972360102 @default.
• W1442691982 hasRelatedWork W2051899593 @default.
• W1442691982 hasRelatedWork W2056343020 @default.
• W1442691982 hasRelatedWork W2081132117 @default.
• W1442691982 hasRelatedWork W2091597535 @default.
• W1442691982 hasRelatedWork W2094908977 @default.
• W1442691982 hasRelatedWork W2097667200 @default.
• W1442691982 hasRelatedWork W2104199435 @default.
• W1442691982 hasRelatedWork W2114964894 @default.
• W1442691982 hasRelatedWork W2128153734 @default.
• W1442691982 hasRelatedWork W2323699661 @default.
• W1442691982 hasRelatedWork W2402380592 @default.
• W1442691982 hasRelatedWork W2419638685 @default.
• W1442691982 hasRelatedWork W2575432205 @default.
• W1442691982 hasRelatedWork W2900299393 @default.
• W1442691982 hasRelatedWork W2971468587 @default.
• W1442691982 hasRelatedWork W3210205408 @default.
• W1442691982 hasVolume "1" @default.
• W1442691982 isParatext "false" @default.
• W1442691982 isRetracted "false" @default.
• W1442691982 magId "1442691982" @default.
• W1442691982 workType "article" @default.